Clinical Development intermediate
Peptide Clinical Trial Design
Design considerations for clinical trials of peptide therapeutics including dosing, endpoints, and safety monitoring.
By Encyclopeptide Editorial | 1 min read
clinical-trial design therapeutic efficacy safety
Overview
Clinical trials for peptide therapeutics require specialized design considerations.
Key Design Elements
Dosing Considerations
- Route: SC, IV, oral, nasal
- Frequency: Daily, weekly, monthly
- Titration: Gradual dose escalation
Endpoints
| Category | Examples |
|---|---|
| Efficacy | HbA1c, weight loss, tumor response |
| Safety | Adverse events, lab values |
| PK/PD | Drug levels, biomarkers |
Statistical Considerations
- Sample size calculations
- Stratification factors
- Adaptive designs
Test Your Knowledge
Reinforce what you learned about Peptide Clinical Trial Design with interactive quizzes on Wikipept.
Take a Quiz on Wikipept